Back to Search
JOSHUA WELLINGTON, M.D.
M.D.
Interventional Pain Medicine Physician
NPI: 1588627251IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pain Medicine (Physical Medicine & Rehabilitation) Physician
Physical Medicine & Rehabilitation — Pain Medicine
Code: 2081P2900X
01058918A(IN)
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
01058918A(IN)
Education
MEDICAL COLLEGE OF OHIO
Class of 1999
Research & Publications (15)
Prepubertal primordial follicle loss in mice is not due to classical apoptotic pathways.
PMID 19264701·Biol Reprod·2009
7-preclinical
Host cell tropism of equine herpesviruses: glycoprotein D of EHV-1 enables EHV-4 to infect a non-permissive cell line.
PMID 17171298·Arch Virol·2007
7-preclinical
EHV-1 and EHV-4 infection in vaccinated mares and their foals.
PMID 16513181·Vet Immunol Immunopathol·2006
7-preclinical
Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
PMID 16504306·Vet Immunol Immunopathol·2006
7-preclinical
Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
PMID 16473414·Vet Immunol Immunopathol·2006
7-preclinical
Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
PMID 15797474·Vet Immunol Immunopathol·2005
4-observational
The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.
PMID 14990719·J Virol·2004
7-preclinical
Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model.
PMID 14505091·Arch Virol·2003
7-preclinical
The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
PMID 11958459·Arch Virol·2002
7-preclinical
Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease.
PMID 11551653·Virus Res·2001
7-preclinical
Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial.
PMID 11420932·Vet Dermatol·2001
4-observational
EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
PMID 11205124·Arch Virol·2000
7-preclinical
Characterisation of IE and UL5 gene products of equine herpesvirus 1 using DNA inoculation of mice.
PMID 11205113·Arch Virol·2000
4-observational
Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
PMID 10946142·Vet Microbiol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11595 N MERIDIAN ST STE 402
CARMEL, IN 46032 - Phone
- (317) 706-7246
Quick Facts
- NPI
- 1588627251
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 27
- Publications
- 15
Are you this provider?
Claim Your Profile